correction to: Imidazole Type Antifungal Drugs Are Effective Colistin Adjuvants That Resensitize Colistin-Resistant Enterobacteriaceae (Adv. Therap., (2020), 3, (2000084), 10.1002/adtp.202000084)

Chen Xu, Kaichao Chen, Kin Fai Chan, Edward Wai Chi Chan, Xuyun Guo, Hoi Yee Chow, Guangming Zhao, Ping Zeng, Miaomiao Wang, Ye Zhu, Xuechen Li, Kwok Yin Wong, Sheng Chen*

Research output: Journal article publicationComment/debate/erratum

1 Citation (Scopus)

Abstract

The originally published Figure 7 was inadvertently a copy of Figure S5. The correct figure 7 reports the data for mcr-1-bearing E. coli rather than E. coli J53. The conclusions of the work are not affected by this error. The authors apologizes for any inconvenience caused. 1 Figure (Figure presented.).

Original languageEnglish
Article number2000182
JournalAdvanced Therapeutics
Volume3
Issue number12
DOIs
Publication statusPublished - Dec 2020

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Pharmacology
  • Pharmaceutical Science
  • Genetics(clinical)
  • Biochemistry, medical
  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'correction to: Imidazole Type Antifungal Drugs Are Effective Colistin Adjuvants That Resensitize Colistin-Resistant Enterobacteriaceae (Adv. Therap., (2020), 3, (2000084), 10.1002/adtp.202000084)'. Together they form a unique fingerprint.

Cite this